Atria Investments Inc Has $5.58 Million Position in Synopsys, Inc. (NASDAQ:SNPS)

Atria Investments Inc lowered its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 18.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 11,021 shares of the semiconductor company's stock after selling 2,414 shares during the quarter. Atria Investments Inc's holdings in Synopsys were worth $5,581,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. boosted its position in shares of Synopsys by 2.1% during the 1st quarter. Vanguard Group Inc. now owns 13,829,357 shares of the semiconductor company's stock worth $7,903,478,000 after purchasing an additional 278,265 shares in the last quarter. Capital World Investors raised its position in shares of Synopsys by 12.5% during the first quarter. Capital World Investors now owns 7,369,890 shares of the semiconductor company's stock worth $4,211,892,000 after acquiring an additional 818,485 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its position in Synopsys by 39.6% during the first quarter. Price T Rowe Associates Inc. MD now owns 5,337,602 shares of the semiconductor company's stock valued at $3,050,441,000 after purchasing an additional 1,514,449 shares during the last quarter. GQG Partners LLC boosted its holdings in shares of Synopsys by 91.6% in the 1st quarter. GQG Partners LLC now owns 2,095,100 shares of the semiconductor company's stock valued at $1,197,350,000 after purchasing an additional 1,001,371 shares in the last quarter. Finally, Swedbank AB raised its stake in Synopsys by 1.4% during the 2nd quarter. Swedbank AB now owns 1,866,133 shares of the semiconductor company's stock worth $1,110,461,000 after buying an additional 25,999 shares during the period. Hedge funds and other institutional investors own 85.47% of the company's stock.

Insider Buying and Selling

In related news, CEO Sassine Ghazi sold 10,293 shares of Synopsys stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $553.89, for a total transaction of $5,701,189.77. Following the sale, the chief executive officer now owns 62,568 shares of the company's stock, valued at $34,655,789.52. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.66% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

SNPS has been the topic of several recent analyst reports. Rosenblatt Securities reissued a "buy" rating and issued a $635.00 target price on shares of Synopsys in a research note on Friday, August 23rd. Mizuho initiated coverage on Synopsys in a research note on Tuesday, October 22nd. They issued an "outperform" rating and a $650.00 target price on the stock. Piper Sandler cut their target price on Synopsys from $687.00 to $670.00 and set an "overweight" rating on the stock in a research note on Thursday, October 24th. Needham & Company LLC reissued a "buy" rating and issued a $640.00 target price on shares of Synopsys in a research note on Tuesday, October 22nd. Finally, Berenberg Bank assumed coverage on shares of Synopsys in a report on Tuesday, October 15th. They issued a "buy" rating and a $660.00 target price for the company. Twelve equities research analysts have rated the stock with a buy rating, According to MarketBeat, the stock currently has a consensus rating of "Buy" and an average price target of $649.82.

Synopsys Stock Performance

Shares of SNPS stock traded down $2.79 during mid-day trading on Tuesday, hitting $553.47. The company's stock had a trading volume of 607,181 shares, compared to its average volume of 1,063,477. The stock has a market cap of $85.02 billion, a price-to-earnings ratio of 57.70, a PEG ratio of 3.42 and a beta of 1.08. The business has a 50-day moving average price of $508.51 and a 200 day moving average price of $545.23. Synopsys, Inc. has a 52-week low of $457.52 and a 52-week high of $629.38.

Synopsys (NASDAQ:SNPS - Get Free Report) last posted its quarterly earnings data on Wednesday, August 21st. The semiconductor company reported $3.43 earnings per share for the quarter, topping analysts' consensus estimates of $3.28 by $0.15. Synopsys had a net margin of 24.06% and a return on equity of 22.09%. The company had revenue of $1.53 billion during the quarter, compared to analysts' expectations of $1.52 billion. During the same period in the prior year, the business posted $2.17 earnings per share. The firm's revenue for the quarter was up 12.7% on a year-over-year basis. Equities research analysts predict that Synopsys, Inc. will post 9.45 EPS for the current fiscal year.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.